TY - JOUR
T1 - Unraveling the relationship between microbial translocation and systemic immune activation in HIV infection
AU - Shan, Liang
AU - Siliciano, Robert F.
PY - 2014/6/2
Y1 - 2014/6/2
N2 - Chronic immune activation is a key factor in HIV-1 disease progression. The translocation of microbial products from the intestinal lumen into the systemic circulation occurs during HIV-1 infection and is associated closely with immune activation; however, it has not been determined conclusively whether microbial translocation drives immune activation or occurs as a consequence of HIV-1 infection. In an important study in this issue of the JCI, Kristoff and colleagues describe the role of microbial translocation in producing immune activation in an animal model of HIV-1 infection, SIV infection of pigtailed macaques. Blocking translocation of intestinal bacterial LPS into the circulation dramatically reduced T cell activation and proliferation, production of proinflammatory cytokines, and plasma SIV RNA levels. This study directly demonstrates that microbial translocation promotes the systemic immune activation associated with HIV-1/SIV infection.
AB - Chronic immune activation is a key factor in HIV-1 disease progression. The translocation of microbial products from the intestinal lumen into the systemic circulation occurs during HIV-1 infection and is associated closely with immune activation; however, it has not been determined conclusively whether microbial translocation drives immune activation or occurs as a consequence of HIV-1 infection. In an important study in this issue of the JCI, Kristoff and colleagues describe the role of microbial translocation in producing immune activation in an animal model of HIV-1 infection, SIV infection of pigtailed macaques. Blocking translocation of intestinal bacterial LPS into the circulation dramatically reduced T cell activation and proliferation, production of proinflammatory cytokines, and plasma SIV RNA levels. This study directly demonstrates that microbial translocation promotes the systemic immune activation associated with HIV-1/SIV infection.
UR - http://www.scopus.com/inward/record.url?scp=84902149445&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84902149445&partnerID=8YFLogxK
U2 - 10.1172/JCI75799
DO - 10.1172/JCI75799
M3 - Review article
C2 - 24837427
AN - SCOPUS:84902149445
SN - 0021-9738
VL - 124
SP - 2368
EP - 2371
JO - Journal of Clinical Investigation
JF - Journal of Clinical Investigation
IS - 6
ER -